Investing.com — Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an “overweight” rating, shifting from “equal-weight,” and have…
The three-time consecutive NBA Slam Dunk champion has reportedly found a home. After spending time in the G League with…